6 completed. 6 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Completed 6 |
| Phase 2 | 2 | Completed 2 |
Follow Pemphigus: new trials by email Literature Review of Pemphigus trials Research Report on Pemphigus
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess the Efficacy and Safety of a Subcutaneous Formulation of Efgartigimod PH20 SC in Adults With Pemphigus (Vulgaris or Foliaceus) efgartigimod PH20 SC, Placebo, prednisone - Pemphigus Vulgaris, Pemphigus Foliaceus | Phase 3 | Completed | argenx | 222 | 2020-12-01 | 2024-10-01 |
| A Study to Evaluate the Efficacy and Safety of Rituximab Versus Mycophenolate Mofetil (MMF) in Participants With Pemphigus Vulgaris (PV) Mycophenolate Mofetil Placebo, Mycophenolate Mofetil, Rituximab - Pemphigus Vulgaris | Phase 3 | Completed | Hoffmann-La Roche | 135 | 2015-05-26 | 2020-11-10 |
| Long-term Clinical and Biological Evaluation of Patients With Severe Forms of Pemphigus Treated by Rituximab Rituximab - Pemphigus | Phase 3 | Completed | University Hospital, Rouen | 22 | 2011-06-01 | 2012-09-13 |
| A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Patients With Active Pemphigus Vulgaris (PV) Mycophenolate Mofetil 2 g/Day, Mycophenolate Mofetil (MMF) 3 g/Day, Placebo - Pemphigus Vulgaris (PV) | Phase 3 | Completed | Hoffmann-La Roche | 96 | 2004-05-01 | 2011-06-22 |
| Effect of Anti CD20 in Pemphigus Desease Mabthera - Pemphigus | Phase 2 / Phase 3 | Completed | University Hospital, Rouen | 22 | 2003-06-01 | 2013-06-18 |
| European Trial of Adjuvant Oral Glucocorticoid Pulse Therapy in Pemphigus dexamethasone (50mg 1dd6, 3 consecutive days/month) - Pemphigus | Phase 2 / Phase 3 | Completed | University Medical Center Groningen | 60 | 2001-01-01 | 2007-08-30 |
Autoimmune Diseases (6) · Immune System Diseases (6) · Skin Diseases (6) · Skin Diseases, Vesiculobullous (6) · Skin and Connective Tissue Diseases (6)
Rituximab (3) · Mycophenolic Acid (2) · Dexamethasone (1) · Prednisone (1)
Hoffmann-La Roche (2) · University Hospital, Rouen (2) · University Medical Center Groningen (1) · argenx (1)
France (4) · Germany (3) · Israel (3) · Turkey (Türkiye) (3) · Ukraine (3) · United States (3) · Australia (2) · Canada (2) · Italy (2) · Spain (2) · United Kingdom (2) · Argentina (1) · Brazil (1) · Bulgaria (1) · China (1)
PMID 16702494, PMID 17687130, PMID 20410913, PMID 34097368
2014 (1)